Amber Cragg

516 total citations
18 papers, 243 citations indexed

About

Amber Cragg is a scholar working on Geriatrics and Gerontology, Toxicology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Amber Cragg has authored 18 papers receiving a total of 243 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Geriatrics and Gerontology, 10 papers in Toxicology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Amber Cragg's work include Pharmaceutical Practices and Patient Outcomes (12 papers), Pharmacovigilance and Adverse Drug Reactions (10 papers) and Pharmaceutical studies and practices (5 papers). Amber Cragg is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (12 papers), Pharmacovigilance and Adverse Drug Reactions (10 papers) and Pharmaceutical studies and practices (5 papers). Amber Cragg collaborates with scholars based in Canada, New Zealand and United States. Amber Cragg's co-authors include Corinne M. Hohl, Jeffrey P. Hau, Mark Asbridge, Donald B. Langille, Daniel Rasic, Mary M. Doyle‐Waters, Christine Liu, Sophie A. Kitchen, Maeve E. Wickham and Frank Scheuermeyer and has published in prestigious journals such as PLoS ONE, BMC Medical Research Methodology and Annals of Emergency Medicine.

In The Last Decade

Amber Cragg

16 papers receiving 238 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amber Cragg Canada 7 88 55 53 47 41 18 243
Ashish P. Thakrar United States 13 241 2.7× 21 0.4× 40 0.8× 98 2.1× 55 1.3× 32 397
Dawn Lindsay United States 14 162 1.8× 44 0.8× 61 1.2× 15 0.3× 53 1.3× 40 443
Launette Rieb Canada 10 164 1.9× 10 0.2× 14 0.3× 52 1.1× 31 0.8× 18 287
Brandi P. Cotton United States 10 96 1.1× 40 0.7× 60 1.1× 19 0.4× 35 0.9× 26 307
Laura Palombi United States 14 250 2.8× 129 2.3× 51 1.0× 46 1.0× 52 1.3× 42 454
Zachary Smothers United States 11 222 2.5× 86 1.6× 67 1.3× 37 0.8× 34 0.8× 13 368
Kara Zamora United States 13 170 1.9× 21 0.4× 91 1.7× 92 2.0× 34 0.8× 27 471
Tanvee Thakur United States 11 177 2.0× 111 2.0× 17 0.3× 43 0.9× 67 1.6× 26 323
Julia Zur United States 9 125 1.4× 9 0.2× 49 0.9× 20 0.4× 55 1.3× 24 353
Lindsay A Pearce Canada 9 243 2.8× 16 0.3× 25 0.5× 43 0.9× 75 1.8× 22 356

Countries citing papers authored by Amber Cragg

Since Specialization
Citations

This map shows the geographic impact of Amber Cragg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amber Cragg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amber Cragg more than expected).

Fields of papers citing papers by Amber Cragg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amber Cragg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amber Cragg. The network helps show where Amber Cragg may publish in the future.

Co-authorship network of co-authors of Amber Cragg

This figure shows the co-authorship network connecting the top 25 collaborators of Amber Cragg. A scholar is included among the top collaborators of Amber Cragg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amber Cragg. Amber Cragg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wickham, Maeve E., Kimberlyn McGrail, Michael R. Law, Amber Cragg, & Corinne M. Hohl. (2024). Re‐Exposure to Culprit Medication Following Adverse Drug Event Diagnosis in Canadian Emergency Department Patients: A Cohort Study. Pharmacoepidemiology and Drug Safety. 33(9). e70012–e70012.
2.
Wickham, Maeve E., Kimberlyn McGrail, Michael R. Law, Amber Cragg, & Corinne M. Hohl. (2024). Validating use of diagnostic codes in Canadian administrative data for identification of adverse drug events. British Journal of Clinical Pharmacology. 90(7). 1688–1698. 2 indexed citations
3.
Wickham, Maeve E., Kimberlyn McGrail, Michael R. Law, Amber Cragg, & Corinne M. Hohl. (2024). Validating methods used to identify non‐adherence adverse drug events in Canadian administrative health data. British Journal of Clinical Pharmacology. 90(5). 1240–1246. 1 indexed citations
5.
Lau, Erica Y., et al.. (2023). An external facilitation intervention to increase uptake of an adverse drug event reporting intervention. Frontiers in Health Services. 3. 1106586–1106586. 2 indexed citations
7.
Hohl, Corinne M., Amber Cragg, Finlay A. McAlister, et al.. (2023). Comparing methods to classify admitted patients with SARS-CoV-2 as admitted for COVID-19 versus with incidental SARS-CoV-2: A cohort study. PLoS ONE. 18(9). e0291580–e0291580. 3 indexed citations
8.
Hau, Jeffrey P., Penelope M. A. Brasher, Amber Cragg, et al.. (2021). Using ActionADE to create information continuity to reduce re-exposures to harmful medications: study protocol for a randomized controlled trial. Trials. 22(1). 119–119. 5 indexed citations
9.
Cragg, Amber, Jeffrey P. Hau, Sophie A. Kitchen, et al.. (2019). Risk Factors for Misuse of Prescribed Opioids: A Systematic Review and Meta-Analysis. Annals of Emergency Medicine. 74(5). 634–646. 97 indexed citations
11.
Cragg, Amber, et al.. (2019). Preventable adverse drug events: Descriptive epidemiology. British Journal of Clinical Pharmacology. 86(2). 291–302. 23 indexed citations
12.
Cragg, Amber, et al.. (2018). Methods for evaluating adverse drug event preventability in emergency department patients. BMC Medical Research Methodology. 18(1). 160–160. 13 indexed citations
13.
Cragg, Amber, et al.. (2017). Risk factors for addiction among patients receiving prescribed opioids: a systematic review protocol. Systematic Reviews. 6(1). 265–265. 10 indexed citations
14.
Cragg, Amber, et al.. (2017). LO92: Factors contributing to the development of adverse drug events treated in emergency departments. Canadian Journal of Emergency Medicine. 19(S1). S59–S60. 1 indexed citations
15.
Small, Serena S, et al.. (2017). Action ADE. 279–282. 1 indexed citations
16.
Wilson, Kevin, Audrey Steenbeek, Mark Asbridge, Amber Cragg, & Donald B. Langille. (2015). Sexual health among female Aboriginal university students in the Maritime Provinces of Canada: risk behaviours and health services use. Sexual Health. 13(1). 35–42. 2 indexed citations
17.
Langille, Donald B., Mark Asbridge, Amber Cragg, & Daniel Rasic. (2015). Associations of School Connectedness with Adolescent Suicidality: Gender Differences and the Role of Risk of Depression. The Canadian Journal of Psychiatry. 60(6). 258–267. 54 indexed citations
18.
Langille, Donald B., Mark Asbridge, Sunday Azagba, et al.. (2014). Sex Differences in Associations of School Connectedness With Adolescent Sexual Risk‐Taking in Nova Scotia, Canada. Journal of School Health. 84(6). 387–395. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026